NALCN and cancer: MGAT4C, HSPA4L, ZSCAN5A, LOC100505841, and NALCN gene deletions were associated with cancer patients without FCH (p < 0.05), while SMYD3 and NKD2DSV genes were associated with cancer patients with FCH (p < 0.05).